Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 5/20 | 0.67 |
| ▸ | JAK1 | P23458 | 4/20 | 0.67 |
| ▸ | NPC1 | O15118 | 5/20 | 0.57 |
| ▸ | RAB9A | P51151 | 5/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.48 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.48 |
| ▸ | MAT2A | P31153 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | CCR3 | P51677 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.46 |
| ▸ | CLK1 | P49759 | 1/20 | 0.46 |
| ▸ | CLK2 | P49760 | 1/20 | 0.46 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5405984 | 0.81 | ROCK2 (0.53) | POLBROCK2ROCK1DYRK3CLK2 | |
| SCHEMBL5859617 | 0.78 | NPC1 (0.56) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL5857039 | 0.76 | JAK2 (0.72) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL5422010 | 0.74 | POLB (0.79) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL25131975 | 0.74 | NPC1 (0.75) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL5412609 | 0.74 | MAOB (0.55) | MAOBROCK2ROCK1RXFP1DYRK3 | |
| SCHEMBL15764657 | 0.73 | JAK2 (1.00) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL15764656 | 0.73 | NPC1 (0.81) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL15764662 | 0.73 | NPC1 (1.00) | JAK2JAK1NPC1RAB9AMAOB | |
| SCHEMBL12628038 | 0.72 | POLB (0.52) | POLBROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7012081-B2 | Anthranyl amides and their use as medicaments | SCHERING AG (DE) | 2006-03-14 | — | — | US | disclosed |
| US-20050261343-A1 | Anthranilamides and their use as pharmaceutical agents | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-11-24 | — | — | US | disclosed |
| US-20040029880-A1 | Anthranyl amides and their use as medicaments | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261343-A1 | Anthranilamides and their use as pharmaceutical agents | AADAC, ANTXR2, VEGFA | JAK2 864/4885JAK1 3384/4885NPC1 3872/4885 |
| US-20040029880-A1 | Anthranyl amides and their use as medicaments | AADAC, ANTXR2, VEGFA | JAK2 1257/4885JAK1 3839/4885NPC1 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.